Clinical Trials Directory

Trials / Unknown

UnknownNCT04593446

Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery

Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery : Phase II. Prospective, Randomised, Multicenter, Non-inferiority Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
414 (estimated)
Sponsor
National Cancer Center, Korea · Other Government
Sex
All
Age
19 Years – 75 Years
Healthy volunteers
Accepted

Summary

This is a prospective randomized study to evaluate the difference in the rate of surgical site infection between the patients who used Sodium Picosulfate solution(PicosolutionⓇ) and tablet Oral Sulphate Solution(ORA·FANGⓇ) for bowel preparation before colorectal cancer surgery .

Detailed description

It has been reported that tablet oral sulphate solution(ORA·FANGⓇ) showed a successful bowel cleansing rate of 95.5%, which is similar to compared to sodium picosulfate solution(PicosolutionⓇ). In terms of the rate of surgical site infection(SSI), sodium picosulfate solution(PicosolutionⓇ) showed 8% of SSI rate. However there is no report for the SSI rate of tablet oral sulphate solution(ORA·FANGⓇ). We aimed to compare the SSI rates between these two group.

Conditions

Interventions

TypeNameDescription
DRUGOral Sulfate Tablet(ORA·FANGⓇ)Subjects who are randomized into experimental arm will receive 14 pills at 8 pm in the evening 2days before the surgery and another 14 pills on 6am in the morning 1day before the surgery Subjects who are randomized into comparator will receive 170ml of solution with at 8 pm in the evening 2days before the surgery and another 170ml of solution on 6am in the morning 1day before the surgery
DRUGSodium Picosulfate Solution(PicosolutionⓇ)Sodium Picosulfate Solution(PicosolutionⓇ)

Timeline

Start date
2020-11-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2020-10-20
Last updated
2020-10-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04593446. Inclusion in this directory is not an endorsement.